j immunol 2017 1982172-81. dolehmann s hiller j van bergenhenegouwen j knippels lmj garssen j traidl-hoffmann c. in vitro evidence for immune-modulatory properties of non-digestible oligosaccharides direct effect on human monocyte derived dendritic cells.

j pediatr rio j 2014 907-15. dorosenbauer j herzig p kaiser p giani g. early nutrition and risk of type 1 diabetes mellitus - a nationwide case-control study in preschool children.

fut2 nonfunctional variant a missing link between genes and environment in type 1 diabetes diabetes 2011 602685-7. dothurl s munzert m henker j boehm g muller-werner b jelinek j et al.

these components might play a key role in healthy immune development and creating a fit and resilient immune system in early and later life.keywords type 1 diabetes gut microbiota mucosal immunity tolerogenic dendritic cells short-chain fatty acids human milk oligosaccharides abbreviations 2'-fl 2'-fucosyllactose 3'-sl 3'-sialyllactose 6'-sl 6'-sialyllactose apc antigen-presenting cells bb-dp biobreeding diabetes prone cramp cathelicidin-related antimicrobial peptide dc dendritic cell dc-sign dendritic cell- specific intercellular adhesion molecule-3-grabbing non-integrin foxp3 forkhead box protein 3 fut 2 fucosyltransferase 2 gad glutamic acid decarboxylase gf germ-free gi tract gastrointestinal tract gpcr g-protein-coupled receptor hat histone acetyl transferase hdac histone deacetylase hif hypoxia inducible factor hmos human milk oligosaccharides jam junction adhesion molecule lcfos long-chain fructo-oligosaccharides lnnt lacto-n-neotetraose mhc-i ii major histocompatibility complex class i ii molecules nod non-obese diabetic ra retinoic acid scfas short-chain fatty acids scgos short-chain galacto-oligosaccharides spf specific pathogen free t1d type 1 diabetes tdc tolerogenic dendritic cells th t-helper cell tj tight junction tlrs toll-like receptors tr1 type-1 regulatory t cells tregs regulatory t cells thsup t helper suppressor cells.introductiontype 1 diabetes t1d is one of the most common autoimmune diseases which develop during infancy and results in t-cell- mediated destruction of b-cells within the pancreas in especially genetically susceptible individuals .

incidence trends of type 1 and type 2 diabetes among youths 2002-2012. n engl j med 2017 3761419-29. dorewers m ludvigsson j. environmental risk factors for type 1 diabetes.lancet lond engl 2016 3872340-8. dovaarala o atkinson ma neu j. the perfect storm for type 1 diabetes the complex interplay between intestinal microbiota gut permeability and mucosal immunity.

diabetologia 2010 53741-8. dokuitunen m saukkonen t ilonen j akerblom hk savilahti e. intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the hla-dqb102 allele.

lancet lond engl2014 38369-82. dowesterholm-ormio m vaarala o pihkala p ilonen j savilahti e. immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes.

diabetes 2003 522287-95. dotiittanen m westerholm-ormio m verkasalo m savilahti e vaarala o. infiltration of forkhead box p3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes.

in this review dietary interventions with scfas and hmos have been discussed as examples of environmental factor-induced complex interplay between intestinal microbiota intestinal bar- rier function and immunity in the development of t1d.pathogenesis of t1dmolecular pathogenic mechanisms of t1dtype 1 diabetes is an autoimmune disorder that involves several components of the immune system negatively interacting withpancreatic islets.

am j physiol gastrointest liver physiol 2000 279g250-4.neu j reverte cm mackey ad liboni k tuhacek-tenace lm hatch m et al.

j immunol 2010 1853814-8. doemamaullee ja davis j merani s toso c elliott jf thiesen a et al.

j exp med 2002 196255-60. dodhodapkar mv steinman rm krasovsky j munz c bhardwaj n. antigen- specific inhibition of effector t cell function in humans after injection of immature dendritic cells.

eur j immunol 2000 301048-52. doi10.1002 sici1521-41412000043041048aid-immu10483.0.co2-wwaithman j allan rs kosaka h azukizawa h shortman k lutz mbet al.

j immunol 2008 1812483-93. dosteinbrink k wolfl m jonuleit h knop j enk ah.

world j gastroenterol 2007 132826-32. domarino e richards jl mcleod kh stanley d yap ya knight j et al.

